Castaño, R., Arbelaez, J., Gedion, U., and Morales, L.G., “Equitable Financing, Out-of-Pocket Payments and the Role of Health Care Reform in Colombia,” Health Policy and Planning 17, Suppl. 1 (2002): 5–11; World Health Organization, “Financing of Health Care from Households’ Out-of-Pocket Payments, Voluntary Payment Schemes and External Resources,” Health at a Glance: Latin America and the Caribbean 2020 (2020).CrossRefGoogle ScholarPubMed

Sirag, A. and Norashidah, M.N., “Out-of-Pocket Health Expenditure and Poverty: Evidence from a Dynamic Panel Threshold Analysis,” Healthcare 9, no. 5 (2021): at 536.CrossRefGoogle ScholarPubMed

World Health Organization, “Financing of Health Care from Households’ Out-of-Pocket Payments, Voluntary Payment Schemes and External Resources,” Health at a Glance: Latin America and the Caribbean 2020 (2020).Google Scholar

Id. Google Scholar

World Health Organization, World Health Statistics 2023: Monitoring Health for the SDGs, Sustainable Development Goals (2023).Google Scholar

Id. Google Scholar

Id. Google Scholar

OECD, Health Expenditure and Financing, “Health Expenditure Indicators,” available at <https://www.oecd.org/health/health-expenditure.htm> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar

Id. Google Scholar

Id. Google Scholar

World Bank data, April 2023, available at < https://data.worldbank.org/indicator/SH.XPD.OOPC.CH.ZS?locations=ZJ-1W> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar

Mougenot, B. and Herrera-Añazco, P., “A Bibliometric Analysis of Literature on the Out-of-Pocket Expense in Health in Latin America,” Revista Del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo 15, no. 2 (2022): 241–246.Google Scholar

D. Maceira and A. Jiménez, El gasto de bolsillo en salud como indicador clave de equidad y calidad sistémica en Argentina (2022).Google Scholar

Garcia-Diaz, R., “Effective Access to Health Care in Mexico,” BMC Health Services Research 22, no. 1 (2022).CrossRefGoogle ScholarPubMed

Sáenz-Vela, H.M. and Guzmán-Giraldo, Á.M., “Determinants of Household Health Spending in Mexico,” Problemas Del Desarrollo 52, no. 205 (2021): 3–25.Google Scholar

Rivera-Almaraz, A., Manrique-Espinoza, B., Chatterji, S., Naidoo, N., Kowal, P., and Salinas-Rodríguez, A., “Longitudinal Associations of Multimorbidity, Disability and Out-of-Pocket Health Expenditures in Households with Older Adults in Mexico: The Study on Global Ageing and Adult Health (SAGE),” Disability and Health Journal, 12, no. 4 (2019): 665–672.Google Scholar

Nava-Bolaños, I., “Catastrophic Health Expenditures and Households with Older Adults in Mexico,” Papeles de Población 25, no. 99 (2019): 113–142.Google Scholar

Nievas, C.M., Gandini, J.B., and Tapia, A.B., “Desigualdades en el acceso a medicamentos y gasto de bolsillo, realidades del subsistema público de salud en el interior argentino,” Revista de La Facultad de Ciencias Médicas de Córdoba 78, no. 2 (2021): 147–152.Google Scholar

Giménez, E., Caballero, R., Peralta, N., and Araujo, J.M., “Análisis del gasto de bolsillo ante la enfermedad de personas de 60 y más años según su condición de pobreza en Paraguay,” Revista de Salúd Pública Del Paraguay 9, no. 2 (2019).Google Scholar

See Sáenz-Vela and Guzmán-Giraldo, supra note 15.Google Scholar

See Maceira and Jiménez, supra note 13.Google Scholar

Castillo-Laborde, C. and Villalobos Dintrans, P., “Caracterización del gasto de bolsillo en salud en Chile: una mirada a dos sistemas de protección,” Revista Médica de Chile (2013).CrossRefGoogle Scholar

Alvis-Zakzuk, J., Marrugo-Arnedo, C., N.Alvis-Zakzuk, J., de la Rosa, F.G., Florez-Tanus, A., Moreno-Ruiz, D., and Alvis-Guzmán, N., “Out-of-Pocket Catastrophic Health Expenditure in Households of Cartagena, Colombia,” Revista de Salud Pública 20, no. 5 (2018): 591–598.CrossRefGoogle ScholarPubMed

OECD, “Pharmaceutical Spending,” available at <https://data.oecd.org/healthres/pharmaceutical-spending.htm> (last visited September 1, 2023); Mousnad, M.A., Shafie, A.A., and Ibrahim, M.I., “Systematic Review of Factors Affecting Pharmaceutical Expenditures,” Health Policy 116, nos. 2-3 (2014): 137–46.Google ScholarPubMed

World Bank data, supra note 11.Google Scholar

Ministerio de Salud del Perú, Política nacional de medicamentos, R.M. 1240–2004/MINSA December 24, 2004.Google Scholar

ComexPerú, Informe de calidad del gasto público en Salud (2019); Matus-López, M., Toledo, L.P., and Pedraza, C.C., “Evaluación del espacio fiscal para la salud en Perú Investigación original,” in Revista Panamericana de Salud Publica 40, no. 1 (2016).Google Scholar

Guerrero-Ojeda, G.A., “Gasto de Bolsillo en salud y riesgo de pobreza en hogares peruanos. Peru 2917,” Revista Salud & Vida Sipanense 7, no. 2 (2020).Google Scholar

Hernández-Vásquez, A., Vargas-Fernández, R., Magallanes-Quevedo, L., and Bendezu-Quispe, G., “Análisis del gasto de bolsillo en medicamentos e insumos en Perú en 2007 y 2016,” Medwave 20, no. 2 (2020): e7833; L. Magallanes Quevedo, Estudio comparativo del gasto de bolsillo en medicamentos e insumos en salud: Perú 2007-2016, Universidad Nacional Mayor de San Marcos (2019).CrossRefGoogle Scholar

Instituto Nacional de Estadística e Informatica (INEI), “Encuesta Nacional de Hogares,” 2019, available at <https://www.datosabiertos.gob.pe/dataset/encuesta-nacional-de-hogares-enaho-2019-instituto-nacional-de-estad%C3%ADstica-e-inform%C3%A1tica-inei> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar

Id. Google Scholar

Id. Google Scholar

Guerrero-Ojeda, G.A., “Gasto de Bolsillo en Salud y Riesgo de Pobreza en Hgares Peruanos: Peru 2017,” Salud & Vida Sipanense, 7 no. 2 (2020): 27–40.CrossRefGoogle Scholar

INEI, supra note 31.Google Scholar

Id. Google Scholar

Id. Google Scholar

Id. Google Scholar

L. García and C. Rojas, “Determinantes del Gasto del Bolsillo en el Perú, Documento de trabajo 500,” Departamento de Economía, Pontificia Universidad Católica del Perú (PUCP), 2021.Google Scholar

D. Proaño Falconi and E. Bernabé, 2018. “Determinants of Catastrophic Healthcare Expenditure in Peru,” International Journal of Health Economics and Management (May 9, 2018).Google Scholar

Tenorio‑Mucha, et al. (2022), “Using Government Data to Understand the Use and Availability of Medicines for Hypertension and Diabetes: Lessons from Peru,” Journal of Pharmaceutical Policy and Practic 5, no. 1 (2022): 86.CrossRefGoogle Scholar

Instituto Nacional de Estadística e Informática (INEI), “Encuesta Nacional de Hogares, 2019,” <https://www.datosabiertos.gob.pe/dataset/encuesta-nacional-de-hogares-enaho-2019-instituto-nacional-de-estad%C3%ADstica-e-inform%C3%A1tica-inei> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar

Brazilian Institute of Geography and Statistics — IBGE, Contas Satélite de Saúde 2010-2019, Serie Contas Nacionais, # 87 ed., 2022, available at <https://biblioteca.ibge.gov.br/visualizacao/livros/liv101928_informativo.pdf> (last visited September 1, 2023).+(last+visited+September+1,+2023).>Google Scholar

Garcia, L.P., Sant’Anna, A.C., Magalhães, L.C., Santana de Freitas, L.R.S, and Aurea, A.P., “Gastos das famílias brasileiras com medicamentos segundo a renda familiar: análise da Pesquisa de Orçamentos Familiares de 2002-2003 e de 2008-2009,” in Cadernos de Saúde Pública, Rio de Janeiro 29, no. 8 (2013): 1605–1616; T. Menezes, B. Campolina, F.G. Silveira, L.M. Servo, and S.F. Piola, “Capítulo 12: O Gasto e a Demanda das Famílias em Saúde: Uma análise a partir da POF 2002-2003,” in Gasto e Consumo das Famílias Brasileiras Contemporâneas, ed. IPEA, Brasília (DF), 2006.Google Scholar

Domingues, E.P., Andrade, M.V, Chein, F., Santiago, F.S., Perobelli, F.S., and Possa da Motta, G., “Uma análise dos impactos econômicos e setoriais do Programa Farmácia Popular do Brasil,” Pesquisa e Planejamento Econômico 45, no. 3 (2015).Google Scholar

IBGE, National Health Survey PNS, “Pesquisa Nacional de Saúde 2013,” concepts, methodology and microdata for the PNS2013 and PNS 2019, available at <https://www.ibge.gov.br/estatisticas/sociais/saude/29540-2013-pesquisa-nacional-de-saude.html?edicao=9177&t=o-que-e> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar

Id. Google Scholar

A.C.S. Correia, I.V.S. Geracy, M.S.D. Durães, and R.L. Giaocomin, “Desoneração de Medicamentos, Boletim Mensal sobre Subsídios da União,” Edição 14, Dezembro 2019, Ministério da Economia, Secretaria Especial da Fazenda, Brasília (2019).Google Scholar

IBGE, Pesquisa de Orçamentos Familiares 2017-2018: Perfil das Despesas no Brasil: Indicadores Selecionados (2020), ed. IBGE, Rio de Janeiro, 2020.Google Scholar

To calculate the budgetary expenses of the SUS expressed above we included the expenses related to the PFPB. All figures are expressed in US$ of 2018.Google Scholar

According to Viera (2018), federal pharmaceutical spending cover about 80 percent of the total public expenditures on pharmaceuticals in the country, given that 20 percent of these spendings are attributed to states and municipalities. F.S. Vieira, “Evolução do Gasto com Medicamentos do Sistema Único de Saúde no Período de 2010 a 2016,” Texto Para a Discussão 2356, Ed. IPEA, Rio de Janeiro, 2018.Google Scholar

The supply of medicines in the SUS, as defined by the PNAF, is structured into three components: (Basic, Strategic and Specialized). The Basic Component gathers expenses with transfers to states and municipalities acquire basic care medicines and medicines from the Women’s Health Program. The Specialized Component is responsible for expenses with high-cost medicines aimed at of high complexity and transfers for the municipal acquisition of medicines, and the Strategic Component is focused on medicines for diseases and conditions of marked epidemiological importance, with an endemic profile, neglected and of great socioeconomic impact.Google Scholar

Brazilian Institute of Geography and Statistics — IBGE, Contas Satélite de Saúde 2010-2019, Serie Contas Nacionais, # 87 ed., 2022, available at <https://biblioteca.ibge.gov.br/visualizacao/livros/liv101928_informativo.pdf> (last visited September 1, 2023).+(last+visited+September+1,+2023).>Google Scholar

IBGE, “PNS — Pesquisa Nacional de Saúde 2019,” available at <https://ibge.gov.br/en/statistics/social/health/16840-national-survey-of-health.html> (last visited September 1, 2023).+(last+visited+September+1,+2023).>Google Scholar

See Correia et al., supra note 47.Google Scholar

Boing, A.C., Andrade, F.B., Bertoldi, A.D., Peres, K.G.A., Massuda, A., and Boing, A.F., “Prevalências e desigualdades no acesso aos medicamentos por usuários do SistemaÚnico de Saúde no Brasil entre 2013 e 2019 ,” Cadernos de Saúde Pública 38, no. 6 (2022): e00114721.Google Scholar

See supra note 52.Google Scholar

IBGE, “POF — Pesquisa de Orçamentos Familiares 2002/2003,” available at <https://ibge.gov.br/estatisticas/sociais/justica-e-seguranca/19877-2002-2003.html> (last visited September 1, 2023); IBGE, “POF — Pesquisa de Orçamentos Familiares 2017/2018,” available at <https://www.ibge.gov.br/estatisticas/sociais/saude/24786-pesquisa-de-orcamentos-familiares-2.html> (last visited September 1, 2023).+(last+visited+September+1,+2023);+IBGE,+“POF+—+Pesquisa+de+Orçamentos+Familiares+2017/2018,”+available+at++(last+visited+September+1,+2023).>Google Scholar

Id.Google Scholar

IBGE, “Pesquisa de Orçamentos Familiares 2017-2018: Perfil das Despesas no Brasil: Indicadores Selecionados,” ed. IBGE (2020).Google Scholar

The Gini Index used in this work is based on the calculation of inequality according to population intervals. It is defined by the formula where G is the Gini Index, X is the accumulated percentage of the population and Y is the corresponding accumulated percentage of the income, expense of other variable where the concentration measure is applied, in the same population intervals. This index could range from 0 to -1 or 1, where 0 is maximum equity and -1 or 1 represents maximum inequity.Google Scholar

The Kakwani Index (K) is given by the difference between the Gini Index for Household Income (GI) and the Gini Index for Household Health Expenditures (GS), so that: K=GI-GS. If K is positive (GI>GS), health expenses (or drug expenses in the case of this paper) are contributing to improve the general distribution of family income. Similarly, if K is negative (GI<GS), it can be inferred that public health policies are not contributing to equity in income distribution.GS),+health+expenses+(or+drug+expenses+in+the+case+of+this+paper)+are+contributing+to+improve+the+general+distribution+of+family+income.+Similarly,+if+K+is+negative+(GIGoogle Scholar

The Gini coefficients for available household income are lower than those for total household gross income, since available income does not include direct taxes, fees, and other payments to the government that are, in general, progressive.Google Scholar

IBGE, “Pesquisa de Orçamentos Familiares, 2020-2003 and 2017-2018,” ed. IBGE, Rio de Janeiro.Google Scholar

Instituto Nacional de Estadísticas de Costa Rica (INEC), Income and Expenditure National Survey (ENIG) 2018.Google Scholar

H.A. Chamizo García, et al., “Inequidades socioespaciales en el acceso a los medicamentos en Costa Rica: las contradicciones de un modelo de atención solidario,” Población y Salud en Mesoamérica 8, no. 1 (2022).Google Scholar

Id. Google Scholar

Id.Google Scholar

Instituto Nacional de Estadísticas de Costa Rica (INEC), Income and Expenditure National Survey (ENIG) 2018.Google Scholar

Instituto Nacional de Estadísticas de Costa Rica (INEC), Income and Expenditure National Survey (ENIG) 2018.Google Scholar

Id. Google Scholar